Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Colesevelam provides economic benefit in T2DM treatment

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Simons WR, Hagan M.The cost-effectiveness of adding colesevelam hydrochloride to metformin in patients with type 2 diabetes who have not achieved optimal glycemic control. 69th Annual Scientific Sessions of the American Diabetes Association: 320 abstr. 1217-P, 5 Jun 2009. Available from: URL: http://ww2.aievolution.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Colesevelam provides economic benefit in T2DM treatment. Pharmacoecon. Outcomes News 582, 4 (2009). https://doi.org/10.2165/00151234-200905820-00009

    Download citation

    Keywords

    • Placebo Group
    • Metformin
    • Economic Benefit
    • Glycaemic Control
    • American Diabetes Association